Hong Kong Pharma Digital Technology Holdings Limited
HKPD
$1.44
-$0.03-2.04%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 4.61M | 4.61M | 5.55M | 5.55M | 4.84M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 4.61M | 4.61M | 5.55M | 5.55M | 4.84M |
Cost of Revenue | 4.36M | 4.36M | 4.59M | 4.59M | 3.73M |
Gross Profit | 254.80K | 254.80K | 952.80K | 952.80K | 1.11M |
SG&A Expenses | 667.40K | 667.40K | 440.60K | 440.60K | 447.30K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 4.90K | 4.90K | -400.00 | -400.00 | -700.00 |
Total Operating Expenses | 5.03M | 5.03M | 5.03M | 5.03M | 4.17M |
Operating Income | -417.50K | -417.50K | 512.60K | 512.60K | 664.70K |
Income Before Tax | -471.40K | -471.40K | 489.40K | 489.40K | 625.90K |
Income Tax Expenses | -43.60K | -43.60K | 75.20K | 75.20K | 85.60K |
Earnings from Continuing Operations | -427.80K | -427.80K | 414.30K | 414.30K | 540.30K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -427.80K | -427.80K | 414.30K | 414.30K | 540.30K |
EBIT | -417.50K | -417.50K | 512.60K | 512.60K | 664.70K |
EBITDA | -396.70K | -396.70K | 529.70K | 529.70K | 680.90K |
EPS Basic | -0.04 | -0.04 | 0.04 | 0.04 | 0.05 |
Normalized Basic EPS | -0.03 | -0.03 | 0.03 | 0.03 | 0.04 |
EPS Diluted | -0.04 | -0.04 | 0.04 | 0.04 | 0.05 |
Normalized Diluted EPS | -0.03 | -0.03 | 0.03 | 0.03 | 0.04 |
Average Basic Shares Outstanding | 10.41M | 10.41M | 10.00M | 10.00M | 10.00M |
Average Diluted Shares Outstanding | 10.41M | 10.41M | 10.00M | 10.00M | 10.00M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |